Executive Moves Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board. April 12, 2019
Executive Moves Celyad promotes Filippo Petti to CEO Celyad SA (NASDAQ:CYAD) of Belgium named Filippo Petti, currently CFO, to the post of CEO, effective April 1, 2019. March 29, 2019
Executive Moves ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO ContraVir Pharmaceuticals (NASDAQ:CTRV) appointed industry veteran, Robert Foster, as acting CEO, succeeding James Sapirstein. October 3, 2018
Executive Moves 3DS names Sherif Louis as CEO 3D Signatures (TSX:DXD) appointed Sherif Louis, as the company's chief executive officer. September 25, 2018
Executive Moves mdBriefCase names Jason Flowerday as CEO mdBriefCase, a leading provider of online continuing professional development for physicians, pharmacists, nurses, and other allied healthcare professionals, appointed Jason Flowerday as CEO. September 17, 2018
Executive Moves Complexa names Francisco Salva as CEO, president Closely-held Complexa appointed Francisco Salva as the company’s new CEO and president, effective immediately. May 14, 2018